Search Results

Keywords: "United Kingdom"

Australian cannabis company completes first export to UK

April 17, 2020

West Perth-based Little Green Pharma said it completed the first-ever commercial export of Australian-produced medical cannabis oil to the United Kingdom. The shipment moves Australia into competition with countries such as Canada and the Netherlands in the competitive – but so far unlucrative – medical cannabis export market. In March, the U.K. eased import restrictions […]

Read More

New Zealand eases prescription requirement for cannabis-based medicine Sativex

April 9, 2020

Doctors in New Zealand no longer require Ministry of Health approval to prescribe Sativex, according to a new notice published in the country’s official Gazette – a move that could facilitate access to the pharmaceutical-grade, cannabis-based product. Any move to reduce bureaucratic-level processing of cannabinoid prescriptions is seen as a boon for patient access as well […]

Read More

COVID-19 crisis effectively freezes European GMP cannabis inspections in Canada, elsewhere

April 6, 2020

European Union Good Manufacturing Practice (EU-GMP) certification audits involving cannabis facilities in Canada and elsewhere are screeching to a halt given the travel restrictions in place in most of the world because of the coronavirus pandemic. The discontinuation of the audits has meant that some overseas medical cannabis producers can’t receive the key certification to begin […]

Read More

Postponed vote on WHO cannabis recommendations reveals international disagreements, uphill battle ahead

March 6, 2020 · Updated March 9, 2020

The 63rd session of the United Nations Commission on Narcotic Drugs (CND) in Vienna this week laid bare deep divisions in the international community over the World Health Organization (WHO) cannabis scheduling recommendations. Rather than voting on recommendations that would have far-reaching implications for the global cannabis industry, the CND postponed the vote to December. The […]

Read More

UK eases import restrictions for medical cannabis

March 2, 2020

The United Kingdom is easing import restrictions for medical cannabis, a move that is expected to improve the dismal numbers the market has seen to date. Licensed wholesalers of medical marijuana are now able to import larger quantities of cannabis-based products and hold supplies for future distribution, the Home Office and the Department of Health […]

Read More

Vape Hardware in the Spotlight

February 2, 2020 · Updated June 6, 2021

Even before federal health officials singled out the additive vitamin E acetate for the rash of vaping illnesses sweeping the country, cannabis companies scrambled to investigate whether vape cartridges, batteries and other components were to blame. Thus far, vaping hardware hasn’t been formally linked to the illnesses. But dangerous levels of heavy metals have been […]

Read More

Australia expedites review of medical cannabis product Epidiolex

January 30, 2020 · Updated February 3, 2020

The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another. Australian health regulators quietly gave Epidiolex, a cannabidiol medication, orphan designation and priority review status in late 2019. The designations allow the Therapeutic Goods Administration to waive application and evaluation fees, as well as expedite its assessment […]

Read More

Australia says over-the-counter CBD sales ‘could be considered during 2020’

January 29, 2020

A review of cannabidiol products being undertaken by Australian health authorities could result in the relaxation of the scheduling status of CBD, potentially making it available over the counter in low doses. In a public submission to a Senate committee studying Australia’s medical cannabis access scheme, the Department of Health said the Therapeutic Goods Administration […]

Read More

GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug

January 13, 2020

A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana. London-based GW Pharmaceuticals told investors Monday that it rang up $108 million in sales last quarter and $309 million for calendar 2019. The company’s fourth-quarter sales beat consensus analyst expectations of $102.4 million. GW attributed the sales figures to physicians […]

Read More

The Big Year

January 1, 2020 · Updated June 6, 2021

Cannabis companies are wagering hundreds of millions of dollars on Colombia’s emerging cannabis industry, betting the Latin American country will become a major production and export hub. But 2019 wasn’t the year in which these businesses began churning out medical cannabis products. This year will be key for Colombian operators to show investors that the […]

Read More

The future of the medical marijuana industry: Q&A with Andrea Small-Howard, chief science officer at GB Sciences

December 12, 2019 · Updated October 8, 2021

Andrea Small-Howard has a unique view into how the medical side of the cannabis space is evolving. She’s the chief science officer at GB Sciences, a Las Vegas-based marijuana company pursuing two strategies – one recreational, and the other aiming for U.S. Food and Drug Administration (FDA) approval of its medical cannabis products. Small-Howard has […]

Read More